Terms: = Lymphoma AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Prognosis
61 results:
1. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
2. PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma.
Sloan SL; Brown F; Long M; Weigel C; Koirala S; Chung JH; Pray B; Villagomez L; Hinterschied C; Sircar A; Helmig-Mason J; Prouty A; Brooks E; Youssef Y; Hanel W; Parekh S; Chan WK; Chen Z; Lapalombella R; Sehgal L; Vaddi K; Scherle P; Chen-Kiang S; Di Liberto M; Elemento O; Meydan C; Foox J; Butler D; Mason CE; Baiocchi RA; Alinari L
Blood; 2023 Sep; 142(10):887-902. PubMed ID: 37267517
[TBL] [Abstract] [Full Text] [Related]
3. Identification and validation of a cellular senescence-related lncRNA signature for prognostic prediction in patients with multiple myeloma.
Zeng T; Jiang S; Wang Y; Sun G; Cao J; Hu D; Wang G; Liang X; Ding J; Du J
Cell Cycle; 2023 Jun; 22(12):1434-1449. PubMed ID: 37227248
[TBL] [Abstract] [Full Text] [Related]
4. Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.
Li N; Lin P; Zuo Z; You MJ; Shuai W; Orlowski R; Manasanch EE; Li S; Xu J; Garces S; Jelloul FZ; Tang Z; Wang W; Medeiros LJ; Yin CC
Cancer Med; 2023 Jul; 12(13):14293-14304. PubMed ID: 37212518
[TBL] [Abstract] [Full Text] [Related]
5. Genotyping of cerebrospinal fluid in lung cancer patients with leptomeningeal metastasis.
Nie N; Zhou H; Zhang K; Liu L; Luo N; Wang R; Li X; Zhu M; Hu C; Wang Y; Liu Z; Li L; He Y
Thorac Cancer; 2022 Sep; 13(18):2574-2583. PubMed ID: 35896160
[TBL] [Abstract] [Full Text] [Related]
6. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
Rai S; Inoue H; Sakai K; Hanamoto H; Matsuda M; Maeda Y; Haeno T; Watatani Y; Kumode T; Serizawa K; Taniguchi Y; Hirase C; Espinoza JL; Morita Y; Tanaka H; Ashida T; Tatsumi Y; Nishio K; Matsumura I
Cancer Sci; 2022 Feb; 113(2):660-673. PubMed ID: 34837284
[TBL] [Abstract] [Full Text] [Related]
7. Coexistence of a secondary STRN-ALK, EML4-ALK double-fusion variant in a lung adenocarcinoma patient with EGFR mutation: a case report.
Zeng Q; Gao H; Zhang L; Qin S; Gu Y; Chen Q
Anticancer Drugs; 2021 Sep; 32(8):890-893. PubMed ID: 34232939
[TBL] [Abstract] [Full Text] [Related]
8. Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.
Imoto N; Koyama D; Sugiura I; Kurahashi S
Medicine (Baltimore); 2021 Feb; 100(5):e24457. PubMed ID: 33592897
[TBL] [Abstract] [Full Text] [Related]
9. Frequency and Correlation of Common Genes Copy Number Alterations in Childhood Acute Lymphoblastic Leukemia with prognosis.
Hosein Pour Feizi A; Zeinali S; Toporski J; Sheervalilou R; Mehranfar S
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3493-3500. PubMed ID: 33369444
[TBL] [Abstract] [Full Text] [Related]
10. Surveilling Russell body
Peruhova M; Peshevska-Sekulovska M; Georgieva V; Panayotova G; Dikov D
World J Gastroenterol; 2020 Sep; 26(33):5050-5059. PubMed ID: 32952348
[TBL] [Abstract] [Full Text] [Related]
11. Frequency and prognostic impact of PAX5 p.P80R in pediatric acute lymphoblastic leukemia patients treated on an AIEOP-BFM acute lymphoblastic leukemia protocol.
Jung M; Schieck M; Hofmann W; Tauscher M; Lentes J; Bergmann A; Stelter M; Möricke A; Alten J; Schlegelberger B; Schrappe M; Zimmermann M; Stanulla M; Cario G; Steinemann D
Genes Chromosomes Cancer; 2020 Nov; 59(11):667-671. PubMed ID: 32592278
[TBL] [Abstract] [Full Text] [Related]
12. Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.
Lejman M; Włodarczyk M; Zawitkowska J; Kowalczyk JR
BMC Med Genomics; 2020 Apr; 13(1):58. PubMed ID: 32245383
[TBL] [Abstract] [Full Text] [Related]
13. The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice.
Nahon-Esteve S; Martel A; Maschi C; Caujolle JP; Baillif S; Lassalle S; Hofman P
Curr Mol Med; 2019; 19(9):632-664. PubMed ID: 31418658
[TBL] [Abstract] [Full Text] [Related]
14. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
[TBL] [Abstract] [Full Text] [Related]
15. BCR-ABL1-like B-Lymphoblastic Leukemia/lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.
Yenamandra AK; Kaviany S; Borinstein SC; Friedman DL; Kovach AE
Lab Med; 2019 Oct; 50(4):401-405. PubMed ID: 30938769
[TBL] [Abstract] [Full Text] [Related]
16. Genomic subtyping and therapeutic targeting of acute erythroleukemia.
Iacobucci I; Wen J; Meggendorfer M; Choi JK; Shi L; Pounds SB; Carmichael CL; Masih KE; Morris SM; Lindsley RC; Janke LJ; Alexander TB; Song G; Qu C; Li Y; Payne-Turner D; Tomizawa D; Kiyokawa N; Valentine M; Valentine V; Basso G; Locatelli F; Enemark EJ; Kham SKY; Yeoh AEJ; Ma X; Zhou X; Sioson E; Rusch M; Ries RE; Stieglitz E; Hunger SP; Wei AH; To LB; Lewis ID; D'Andrea RJ; Kile BT; Brown AL; Scott HS; Hahn CN; Marlton P; Pei D; Cheng C; Loh ML; Ebert BL; Meshinchi S; Haferlach T; Mullighan CG
Nat Genet; 2019 Apr; 51(4):694-704. PubMed ID: 30926971
[TBL] [Abstract] [Full Text] [Related]
17. IKZF1
Stanulla M; Dagdan E; Zaliova M; Möricke A; Palmi C; Cazzaniga G; Eckert C; Te Kronnie G; Bourquin JP; Bornhauser B; Koehler R; Bartram CR; Ludwig WD; Bleckmann K; Groeneveld-Krentz S; Schewe D; Junk SV; Hinze L; Klein N; Kratz CP; Biondi A; Borkhardt A; Kulozik A; Muckenthaler MU; Basso G; Valsecchi MG; Izraeli S; Petersen BS; Franke A; Dörge P; Steinemann D; Haas OA; Panzer-Grümayer R; Cavé H; Houlston RS; Cario G; Schrappe M; Zimmermann M; ;
J Clin Oncol; 2018 Apr; 36(12):1240-1249. PubMed ID: 29498923
[TBL] [Abstract] [Full Text] [Related]
18. Genomic CDKN2A/2B deletions in adult Ph
Pfeifer H; Raum K; Markovic S; Nowak V; Fey S; Obländer J; Pressler J; Böhm V; Brüggemann M; Wunderle L; Hüttmann A; Wäsch R; Beck J; Stelljes M; Viardot A; Lang F; Hoelzer D; Hofmann WK; Serve H; Weiss C; Goekbuget N; Ottmann OG; Nowak D
Blood; 2018 Mar; 131(13):1464-1475. PubMed ID: 29348129
[TBL] [Abstract] [Full Text] [Related]
19. The correlation between Pax5 deletion and patients survival in Iranian children with precursor B-cell acute lymphocytic leukemia.
Moafi A; Zojaji A; Salehi R; Najafi Dorcheh S; Rahgozar S
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):19-22. PubMed ID: 28886309
[TBL] [Abstract] [Full Text] [Related]
20. The predicted target gene validation, function, and prognosis studies of miRNA-22 in colorectal cancer tissue.
Li B; Li B; Sun H; Zhang H
Tumour Biol; 2017 Mar; 39(3):1010428317692257. PubMed ID: 28347238
[TBL] [Abstract] [Full Text] [Related]
[Next]
